Website Search
ID 2292

The Biochemistry of Disorders

Doctor Daniel Pine makes the important point that the idea of a 'chemical imbalance' as a cause of disorders has pretty much rightfully been given up.
We do not really talk about levels of brain chemicals anymore because what we know is that it is probably not that meaningful to talk about an overall or average level of a neurochemical. The level of a neurochemical in one specific part of the brain might mean one thing and the level of that very same neurochemical might mean something totally different in another part of the brain. As a rule, we tend not to talk about levels of neurochemicals at all anymore. Someday, and we are not at this point yet, we might talk about levels of neurochemicals in very specific parts of the brain or we might even talk about relationships among levels of neurochemicals, but again we are not really ready to do that. What we are ready to do or at least ready to start thinking about is how we understand activity or functioning in different parts of the brain, relatively specific parts like the amygdala and the prefrontal cortex. We can start thinking about how those functions change when levels of chemicals change in those specific structures. The idea that people used to have about chemical imbalance is an idea that has pretty much rightfully been given up. We do not really talk about chemical imbalances anymore because we realized that that way of thinking about chemicals as if they are in a certain global balance is not correct. We tend to think about circuits or specific brain structures and the connections among them.
brain chemicals, biochemicals, neurochemicals, biochemistry, chemical imbalance, brain, behavior, behaviour, disorder, daniel, danny, pine
Creative Commons License This work by Cold Spring Harbor Laboratory is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License.

Related content:

1165. Dopamine and Schizophrenia
Professor Daniel Weinberger explains that dopamine is the major focus of biochemical research into schizophrenia.
2291. Biochemistry and Anxiety
Doctor Daniel Pine explains that although a lot of work remains to be done, noerpinephrine (noradrenalin) and serotonin are important to understanding the biochemistry of anxiety.
1166. N-Acetylaspartate and Schizophrenia
Professor Daniel Weinberger discusses the role played by the biochemical N-Acetylaspartate in schizophrenia.
1392. Biochemistry of Depression
Doctor Jon Lieberman discusses three neurotransmitters that have been associated with depression - dopamine, serotonin, and norepinephrine.
2163. Dopamine
Professor Philip Shaw discusses some of the main functions associated with the dopamine system, which include reward, punishment, and control of action and attention.
2164. Biochemistry of ADHD - serotonin
Professor Philip Shaw discusses the relationship between serotonin and ADHD.
2293. Genes and Treatment for Depression and Anxiety
Doctor Daniel Pine estimates that approximately 30-50% of the risk for anxiety and depression is genetic. Genetic treatments are an exciting area of research currently.
883. Treating Autism
Exploring the possiblities of 'bringing back' the brain of a child with autism.
2358. Neurotransmitters Systems Work Together
Doctor Ellen Leibenluft explains that neurotransmitters and neuromodulators in the brain are heavily inter-connected and work together as a system.
2294. Understanding Disorders at the Cellular Level
Doctor Daniel Pine discusses the different approaches to understanding disorders and explains that we have a long way to go to understand them on the cellular level.
Cold Spring Harbor Laboratory
CSHL HomeAbout CSHLResearchEducationNews & FeaturesCampus & Public EventsCareersGiving